This article summarizes the most significant insider buys and sells from Thursday's disclosures for US stocks.
Top Insider Buys:
Nuvation Bio Inc. (NYSE:NUVB) saw Director Robert Mashal increase his stake in the company through a substantial purchase. Mashal acquired 100,000 shares of Nuvation Bio's Class A Common Stock on October 8, 2024, at prices ranging from $2.195 to $2.2 per share. The total value of the transaction was approximately $220,000. Following these purchases, Mashal now indirectly owns 100,000 shares through the Robert D. Mashal 2020 Revocable Trust, for which he serves as the sole trustee.
Tharimmune, Inc. (NASDAQ:THAR) CEO Randy Milby demonstrated confidence in his company by purchasing 2,500 shares on October 8th. The shares were acquired at prices between $2.085 and $2.1, totaling an investment of $5,221. This insider buy is often viewed as a positive signal, reflecting the CEO's belief in the company's future prospects.
GATX Corp (NYSE:GATX) received a significant vote of confidence from major shareholder State Farm Mutual Automobile Insurance Co. The insurance giant invested over $3.1 million in GATX stock, purchasing a total of 23,706 shares across two days. The transactions occurred at prices of $133.269 and $133.6518 per share, further solidifying State Farm's position in the transportation services company.
AngioDynamics Inc. (NASDAQ:ANGO) reported an insider purchase by Warren Nighan Jr., the company's Senior Vice President of Quality and Regulatory. Nighan acquired a total of 868 shares in two separate transactions on October 7 and October 10. The shares were purchased at prices of $6.09 and $6.08, respectively, for a total investment of over $5,285.
CITY HOLDING CO (NASDAQ:CHCO) director Robert D. Fisher increased his stake in the company by purchasing 172 shares at $115.0241 each on October 10, 2024. The total investment amounted to $19,784. Following this transaction, Fisher now owns 44,232.3946 shares in CITY HOLDING CO. The purchase was made under a Rule 10b5-1 Plan, a predetermined trading arrangement for company insiders.
Top Insider Sells:
Zoom Video Communications , Inc. (NASDAQ:ZM) CEO Eric Yuan sold a substantial number of shares over several days. The transactions, which occurred on October 9 and 10, 2024, involved the sale of 58,454 shares at prices ranging from $68.12 to $70.9053. The total value of the sales exceeded $4 million.
Jefferies Financial Group Inc. (NYSE:JEF) President Brian P. Friedman divested 200,000 shares on October 10, 2024. The shares were sold at weighted average prices between $63.00 and $63.41, resulting in a total sale value of approximately $12.6 million. Despite this significant sale, Friedman retains substantial holdings in the company through various ownership structures.
Robinhood (NASDAQ:HOOD) Markets, Inc. (NASDAQ:HOOD) Chief Brokerage Officer Steven M. Quirk sold 208,291 shares of Class A Common Stock on October 8, 2024. The transaction, executed under a pre-arranged Rule 10b5-1 plan, netted approximately $5,202,942. The shares were sold at prices ranging from $24.96 to $25.04 throughout the day.
Credo Technology Group Holding Ltd (NASDAQ:CRDO) Director Tan Lip Bu conducted a series of sales between October 8 and October 10. Tan sold a total of 406,954 shares at prices ranging from $33.2315 to $37.0433, with the total value of the transactions exceeding $14 million.
Berkshire Hathaway Inc . (NYSE:BRKa), led by Warren E. Buffett, reported the sale of approximately 9.55 million shares of Bank of America Corp (NYSE:NYSE:BAC) stock. The transactions occurred between October 8 and October 10, with share prices ranging from $39.9175 to $40.1434. The total value of the sales amounted to around $382 million.
Investors should pay attention to insider trading activity as it can provide valuable insights into a company's internal perspective. While insider buys often signal confidence in a company's future, sells may occur for various reasons and should be considered alongside other factors when making investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.